Retatrutide
TRIUMPH-8
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 250
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Retatrutide Dose 1 | Obesity or overweight | n/r | 65 | n/r | n/r |
| Retatrutide Dose 2 | Obesity or overweight | n/r | 65 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 65 | n/r | n/r |